Bavarian Innovation Award for Schreiner Group
Schreiner Group (Oberschleißheim, Germany) received the special jury prize at the Bavarian Innovation Award for an outstanding innovative and technologically complex product development. Dr Ulrike Wolf, ministerial director at the Bavarian Ministry of Economic Affairs, presented the prestigious award for the medical product "Coldplasmapatch", also known as CPTpatch. This is a high-tech pad for the treatment of wounds that is based on printed electronics. It generates cold plasma that kills multi-resistant bacteria, promotes cell regeneration and can thus heal chronic wounds – even if they were previously considered incurable. Schreiner Group realised the innovative product together with the medical technology company Coldplasmatech.
"Successful Bavarian companies like Schreiner Group develop new products for the markets of the future and are courageous and willing to take risks. Thanks to such committed high-tech companies, the Bavarian economy is a leader in research and development and shapes the innovation landscape in Germany and throughout Europe," emphasises Bavarian Minister of Economic Affairs Hubert Aiwanger.
More than 100 specialists work at Schreiner Group in product development alone – always closely oriented to customers' needs and at the same time very successful: Schreiner Group has registered more than 100 patents and is often the preferred development partner of numerous international corporations in the healthcare and mobility sectors. "We are very pleased that with the Coldplasmapatch a development from the future field of printed electronics has been awarded a prize. Innovation is at the forefront of our four corporate values. We are innovative out of deep conviction and passion and want to inspire our customers again and again with smart solutions," emphasises managing director Roland Schreiner.
The Coldplasmapatch shows outstanding results – even in wounds that were classified as non-healable under conventional therapy. The technology is based on the findings of plasma physics, is realised through the use of printed electronics and developed on behalf of and in cooperation with Coldplasmatech GmbH. Highly professional production in a roll-to-roll printing process at Schreiner Group made the product suitable for the mass market. "Our CPTpatch and the associated individual therapy with cold plasma has the potential to revolutionise the wound market in the long term," says Dr Carsten Mahrenholz, founder and managing director of the partner company Coldplasmatech GmbH.
The Bavarian Innovation Prize has been awarded every two years for the past ten years as a joint initiative of the Bavarian Ministry of Economic Affairs, the Association of Bavarian Chambers of Industry and Commerce and the Association of Bavarian Chambers of Crafts.
Caption: Thomas Köberlein, business unit manager of Schreiner ProTech, Dr Carsten Mahrenholz, CEO of Coldplasmatech, and Robert Weiß, head of technology and innovation management at Schreiner Group (photo: Kim Pottkämper)